Between Evergrande and the Fed, little respite for the market

The rebound in European equity markets could continue after Evergrande announced that it had reached an agreement with its creditors on the payment of interest tomorrow on a yuan loan. This seems to confirm that the Chinese authorities will “convince” the domestic creditors to rearrange the repayment terms to avoid a formal default by the property developer. However, there was no word on the interest payment (again on Thursday) on another USD loan ($83.5m), which means that this respite could be short-lived.

In addition, US markets just stabilised yesterday, already looking ahead to the Fed meeting that ends today. It seems almost a foregone conclusion that the Fed will postpone the announcement of the reduction of its securities purchases until the next meeting (early November). The main risk in our view is that Fed members’ rate forecasts show an increase in the probability of tightening as early as 2022 in the face of rising inflationary risk, further highlighted by yesterday’s sharp upward revision of the OECD forecasts.

EnergyScan - Economics news

The EUR/USD exchange rate seems to be stabilising around 1.1720-30.

Share this news :

You might also read :

EnergyScan, webinar, ENGIE, ENGIE Gems, Macro, Oil, Gas, Power, Carbon
January 18, 2023

Is the peak of the energy crisis behind us?

The EnergyScan team held its quarterly webinar covering key trends and events on energy markets. In this webinar, our experts addressed the following topics, with…
ES-power
January 19, 2022

Calm session for the carbon and power markets

The European power spot prices retreated yesterday, pressured by forecasts of surging wind output and higher solar and hydro generation. The day-ahead prices averaged 196.07€/MWh…
ES-power
April 26, 2022

A quick reversal of carbon prices

The European power spot prices inched up yesterday as forecasts of higher demand and falling wind production were mostly offset by expectations of improved French…
Join EnergyScan

Get more analysis and data with our Premium subscription

Ask for a free trial here

Subscribe to our newsletter

Don’t have an account yet? 

[booked-calendar]